Date: 2012-06-25
Type of information: Services contract
Compound: services and technologies for development clinical assessment of lipid-based formulations
Company: Quotient Clinical (UK) Capsugel (USA)
Therapeutic area:
Type agreement: collaboration
services
Action mechanism:
Disease:
Details: Quotient Clinical, a provider of specialist early stage drug development services and Capsugel, a global leader in innovative dosage solutions for the healthcare industry, have announced a collaboration to enable the rapid development and clinical assessment of lipid-based formulations. Together, the companies will use their technology and expertise to address the drug delivery challenges of poorly soluble molecules with limited oral bioavailability.
The collaboration integrates Quotient’s RapidFACT™ real time clinical manufacture and testing service with Capsugel’s lipid-based formulation expertise and manufacturing capability.
With up to 70% of the industry’s development pipeline consisting of molecules with poor solubility, the collaboration will fast track the effective clinical evaluation of lipid-based drug delivery systems in man, whilst optimising the drug product for downstream development.
As part of the collaboration, Quotient will utilise Capsugel’s CFS Liquid Capsule Filling and Sealing technology at its facility in Nottingham and will be able to access the formulation expertise in Capsugel’s Development Centre in Strasbourg (France).
Financial terms:
Latest news:
